Encapsulated cell-based delivery of CNTF reduces photoreceptor degeneration in animal models of retinitis pigmentosa

Investigative Ophthalmology and Visual Science

Volumn 43, Issue 10, 2002, Pages 3292-3298

  Tao, Weng ^a   Wen, Rong ^a   Goddard, Moses B ^a   Sherman, Sandy D ^a   O'Rourke, Pam J ^a   Stabila, Paul F ^a   Bell, William J ^a   Dean, Brenda J ^a   Kauper, Konrad A ^a   Budz, Veronica A ^a   Tsiaras, William G ^a   Acland, Gregory M ^a   Pearce Kelling, Sue ^a   Laties, Alan M ^a   Aguirre, Gustavo D ^a  

^a Neurotech USA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CILIARY NEUROTROPHIC FACTOR; POLYMER;

ADOLESCENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CELL ENCAPSULATION; CELL VIABILITY; DOG; DOSE RESPONSE; GENETIC ENGINEERING; HOLLOW FIBER MEMBRANE; HUMAN; HUMAN CELL; NEUROPROTECTION; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN SECRETION; RETINA DEGENERATION; RETINITIS PIGMENTOSA; TRANSGENIC ANIMAL; VITREOUS BODY;

ANIMALS; ANIMALS, GENETICALLY MODIFIED; CELL LINE; CILIARY NEUROTROPHIC FACTOR; DELAYED-ACTION PREPARATIONS; DOGS; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG DELIVERY SYSTEMS; EQUIPMENT DESIGN; HUMANS; NERVE DEGENERATION; NEUROPROTECTIVE AGENTS; PHOTORECEPTORS; RATS; RETINITIS PIGMENTOSA;

EID: 0036784819     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (51)

1. Leibowitz HM, Kreuger DE, Maunder LR, et al. The Framingham Eye Study monograph: an ophthalmological and epidemiological study of cataract, glaucoma, diabetic retinopathy, macular degeneration, and visual acuity in a general population of 2631 adults, 1973-1975. Surv Ophthalmol. 1980;24(suppl):335-610.
2. Klein BE, Klein R. Cataracts and macular degeneration in older Americans. Arch Ophthalmol. 1982;100:571-573.
3. Martinez GS, Campbell AJ, Reinken J, Allan BC. Prevalence of ocular disease in a population study of subjects 65 years old and older. Am J Ophthalmol. 1982;94:181-189.
4. Gibson JM, Rosenthal AR, Lavery J. A study of the prevalence of eye disease in the elderly in an English community. Trans Opbtbalmol Soc UK. 1985;104:196-203.
5. Vinding T. Age-related macular degeneration: macular changes, prevalence and sex ratio-an epidemiological study of 1000 aged individuals. Acta Opbtbalmol (Copenb). 1989;67:609-616.
6. Bressler NM, Bressler SB, West SK, Fine SL, Taylor HR. The grading and prevalence of macular degeneration in Chesapeake Bay water-men. Arch Opbthalmol. 1989;107:847-852.
7. Klein R, Klein BE, Linton KL. Prevalence of age-related maculopathy: The Beaver Dam Eye Study. Ophthalmology. 1992; 99:933-943.
8. Vingerling JR, Dielemans I, Hofman A, et al. The prevalence of age-related maculopathy in the Rotterdam Study. Ophthalmology. 1995;102:205-210.
9. Hawkins BS, Bird A, Klein R, West SK. Epidemiology of age-related macular degeneration. Mol Vis. 1999;5:26.
10. Davis MD, Hiller R, Magli YL, et al. Prognosis for life in patients with diabetes: relation to severity of retinopathy. Trans Am Ophthalmol Soc. 1979;77:144-170.
11. Podgor MJ, Cassel GH, Kannel WB. Lens changes and survival in a population-based study. N Engl J Med. 1985;313:1438-1444.
12. Klein R, Klein BE, Moss SE, Davis MD, DeMets DL. The Wisconsin epidemiologic study of diabetic retinopathy. II: prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102:520-526.
13. Klein R, Moss SE, Klein BE, DeMets, DL. Relation of ocular and systemic factors to survival in diabetes. Arch Intern Med. 1989; 149:266-272.
14. Klein R, Klein BE, Moss SE. Age-related eye disease and survival: the Beaver Dam Eye Study. Arch Ophthalmol. 1995;113:333-339.
15. Coleman AL. Glaucoma. Lancet. 1999;354:1803-1810.
16. West SK. Looking forward to 20/20: a focus on the epidemiology of eye diseases. Epidemiol Rev. 2000;22:64-70.
17. Hoyng PF, van Beek LM. Pharmacological therapy for glaucoma: a review. Drugs. 2000;59:411-434.
18. Weih LM, VanNewkirk MR, McCarty CA, Taylor HR. Age-specific causes of bilateral visual impairment. Arch Ophthalmol. 2000;118: 264-269.
19. Dryja TP, Li T. Molecular genetics of retinitis pigmentosa. Hum Mol Genet. 1995;4:1739-1743.
20. Holt IJ, Harding AE, Petty RK, Morgan-Hughes JA. A new mitochondrial disease associated with mitochondrial DNA heteroplasmy. Am J Hum Genet. 1990;46:428-433.
21. Narcisi TM, Shoulder CC, Chester SA, et al. Mutations of the microsomal triglyceride-transfer-protein gene in abetalipoproteinemia. Am J Hum Genet. 1995;57:1298-1310.
22. Meindl A, Dry K, Herrmann K, et al. A gene (RPGR) with homology to the RCC1 guanine nucleotide exchange factor is mutated in X-linked retinitis pigmentosa (RP3). Nat Genet. 1996;13:35-42.
23. Lindner MD, Kearns CE, Winn SR, Frydel B, Emerich DF. Effects of intraventricular encapsulated hNGF-secreting fibroblasts in aged rats. Cell Transplant. 1996;5:205-223.
24. Emerich DF, Lindner MD, Winn SR, Chen EY, Frydel BR, Kordower JH. Implants of encapsulated human CNTF-producing fibroblasts prevent behavioral deficits and striatal degeneration in a rodent model of Huntington's disease. J. Neurosci. 1996;16:5168-5181.
25. Emerich DF, Winn SR, Hantraye PM, et al. Protective effect of encapsulated cells producing neurotrophic factor CNTF in a monkey model of Huntington's disease. Nature 1997;386:395-399.
26. Emerich DF, Plone M, Francis J, Frydel BR, Winn SR, Lindner MD. Alleviation of behavioral deficits in aged rodents following implantation of encapsulated GDNF-producing fibroblasts. Brain Res. 1996;736:99-110.
27. Tseng JL, Baetge EE, Zum AD, Aebischer P. GDNF reduces drug-induced rotational behavior after medial forebrain bundle transection by a mechanism not involving striatal dopamine. J Neurosci. 1997;17:325-333.
28. Emerich DF, Hammang JP, Baetge EE, Winn SR. Implantation of polymer-encapsulated human nerve growth factor-secreting fibroblasts attenuates the behavioral and neuropathological consequences of quinolinic acid injections into rodent striatum. Exp Neurol. 1994;130:141-150.
29. Emerich DF, Winn SR, Harper J, Hammang JP, Baetge EE, Kordower JH. Implants of polymer-encapsulated human NGF-secreting cells in the nonhuman primate: rescue and sprouting of degenerating cholinergic basal forebrain neurons. J Comp Neurol. 1994;349:148-164.
30. Kordower JH, Winn SR, Liu YT, et al. The aged monkey basal forebrain: rescue and sprouting of axotomized basal forebrain neurons after grafts of encapsulated cells secreting human nerve growth factor. Proc Natl Acad Sci USA. 1994;91:10898-10902.
31. Hoane MR, Puri K, Xu L, et al. Mammalian-cell-produced neurturin (NTN) is more potent than purified Escherichia coil-produced NTN. Exp Neurol. 2000;162:189-193.
32. Bedell MA, Largaespada DA, Jenkins NA, Copeland NG. Mouse models of human disease. Part II: recent progress and future directions. Genes Dev. 1997;11:11-43.
33. LaVail MM, Sidman M, Rausin R, Sidman RL. Discrimination of light intensity by rats with inherited retinal degeneration: a behavioral and cytological study. Vision Res. 1974;14:693-702.
34. Bowes C, Li T, Danciger M, Baxter LC, Applebury ML, Farber DB. Retinal degeneration in the rd mouse is caused by a defect in the beta subunit of rod cGMP-phosphodiesterase. Nature. 1990;347: 677-680.
35. Pittler SJ, Beahr W, Wasmuth JJ, et al. Molecular characterization of human and bovine rod photoreceptor cGMP phosphodiesterise alpha-subunit and chromosomal localization of the human gene. Genomics 1990;6:272-283.
36. Suber ML, Pittler SJ, Qin N, et al. Irish setter dogs affected with rod/cone dysplasia contain a nonsense mutation in the rod cGMP phosphodiesterase beta-subunit gene. Proc Natl Acad Sci USA. 1993;90:3968-3972.
37. McLaughlin ME, Ehrhart TL, Berson EL, Dryja TP. Mutation spectrum of the gene encoding the beta subunit of rod phosphodiesterase among patients with autosomal recessive retinitis pigmentosa. Proc Natl. Acad Sci USA. 1995;92:3249-3253.
38. Liu C, Li Y, Peng M, Laties AM, Wen R. Activation of caspase-3 in the retina of transgenic rats with the rhodopsin mutation s334ter during photoreceptor degeneration. J Neurosci. 1999;19:4778-4785.
39. Aguirre GF, Farber D, Lolley R, et al. Retinal degenerations in the dog. III: abnormal cyclic nucleotide metabolism in rod-cone dysplasia. Exp. Eye Res. 1982;35:625-642.
40. Faktorovich EG, Steinberg RH, Yasumura D, Matthes MT, LaVail MM. Photoreceptor degeneration in inherited retinal dystrophy delayed by basic fibroblast growth factor. Nature. 1990;347:83-86.
41. LaVail MM, Unoki K, Yasumuri D, Matthes MT, Yancopoulos GD, Steinberg RH. Multiple growth factors, cytokines, and neurotrophins rescue photoreceptors from the damaging effects of constant light. Proc Natl Acad Sci USA. 1992;89:11249-11253.
42. Steinberg RH. Survival factors in retinal degenerations. Curr Opin Neurobiol. 1994;4:515-524.
43. LaVail MM, Yasumura D, Matthes MT, et al. Protection of mouse photoreceptors by survival factors in retinal degenerations. Invest Ophthalmol Vis Sci. 1998;39:592-602.
44. Unoki K, LaVail MM. Protection of the rat retina from ischemic injury by brain-derived neurotrophic factor, ciliary neurotrophic factor, and basic fibroblast growth factor. Invest Ophthalmol Vis Sci. 1994;35:907-915.
45. Schmidt SY, Aguirre GD. Reductions in taurine secondary to photoreceptor loss in Irish setters with rod-cone dysplasia. Invest Ophthalmol Vis Sci. 1985;26:679-683.
46. Rudge JS, Davis GE, Manthorpe M, Varon S. An examination of ciliary neuronotrophic factors from avian and rodent tissue extracts using a blot and culture technique. Brain Res. 1987;429: 103-110.
47. Watters DJ, Hendry IA. Purification of a ciliary neurotrophic factor from bovine heart. J Neurochem, 1987;49:705-713.
48. Lin LF, Armes LG, Sommer A, Smith DJ, Collins F. Isolation and characterization of ciliary neurotrophic factor from rabbit sciatic nerves. J Biol Chem. 1990;265:8942-8947.
49. Gupta SK, Altares M, Benoit R, Riopelle RJ, Dunn RJ, Richardson PM. Preparation and biological properties of native and recombinant ciliary neurotrophic factor. J Neurobiol. 1992;23:481-490.
50. Cayouette M, Gravel C. Adenovirus-mediated gene transfer of ciliary neurotrophic factor can prevent photoreceptor degeneration in the retinal degeneration (rd) mouse. Hum Gene Ther. 1997;8: 423-430.
51. Cayouette M, Behn D, Sendtner M, Lachapelle P, Gravel C. Intraocular gene transfer of ciliary neurotrophic factor prevents death and increases responsiveness of rod photoreceptors in the retinal degeneration slow mouse. J Neurosci. 1998;18:9282-9293.